PSMA, also known as glutamate carboxypeptidase II (GCPII), is overexpressed in almost all types of human PCa as well as in neovascularization of various solid tumors and the expression level of PSMA increases with tumor grade and stage [9–12], but with significantly lower expression in healthy tissues [13, 14]. This evidence concerns the gene FOLH1 and neoplasm.